IOD: Revenue up 16.9% and net loss down 12.9%, but going concern risk persistsQuartr·Aug 30 at 11:30 PM
IOD: FY2026 saw double-digit revenue growth, improved margins, and a strong UK-led platform for FY2027Quartr·Aug 30 at 11:29 PM
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical DevelopmentGlobeNewswire·Apr 9 at 05:00 AM
IODM seals 283‑university U.S. platform deal to fast-track North American growthTip Ranks·Apr 9 at 12:23 AM
IODM Expands Educational Sector Reach with TransferMate PartnershipTip Ranks·Jul 21, 2025 at 11:49 PM
